Abstract
AIM: To summarise the available evidence concerning the incidence and risk factors of UTIs in bladder cancer patients after surgery. METHODS: Systematic searches were conducted on PubMed, Embase, Web of Science, Cochrane Library, CINAHL, the China National Knowledge Base Database (CNKI), Wanfang Database, Vips Database (VIP), and the China Biomedical Database (Sinomed). These searches encompassed literature from the inception of each database up to March 2025. This study adhered rigorously to the PRISMA guidelines. The quality of the studies included in the review was assessed using the Joanna Briggs Institute (JBI) Centre for Evidence-Based Health Care in Australia and the Newcastle-Ottawa Scale. RESULTS: A total of 19 original studies were included in this analysis, encompassing 5,905 patients. The meta-analysis results indicated that the incidence of UTIs in patients with bladder tumor resection was 22.3% [95% CI (17.7, 27.3)]. The identified risk factors for UTIs in patients with bladder cancer after surgery include diabetes, age, preoperative catheter indwelling, Use of antibiotics before surgery, and Operation time≥90 min. CONCLUSIONS: UTIs are higher in patients who have undergone bladder tumor resection. Clinical staff should prioritize preoperative assessment and risk stratification for UTIs. They must adhere to established guidelines and recommendations regarding the prophylactic use of antibiotics before surgery, maintain strict control of patients' blood sugar levels, and manage catheters meticulously to minimize the risk of UTIs.